Description

Ondanset Solution for Injections 2 mg/ml. 2 ml. Vials №5

Ingredients:

Each 2 ml vial contains 4 mg of Ondansetron (as hydrochloride dihydrate) as the active ingredient.

Dosage:

The usual adult dose is 8 mg administered by slow intravenous injection or infusion, or by intramuscular injection immediately before chemotherapy and repeated every 8 hours for 2 doses.

Indications:

Ondanset Solution is indicated for the prevention of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy.

Contraindications:

Do not use Ondanset Solution if you are allergic to ondansetron or any other ingredients in the formulation.

Directions:

Administer the solution as directed by a healthcare professional. Do not exceed the recommended dosage.

Scientific Evidence:

Ondansetron, the active ingredient in Ondanset Solution, is a selective 5-HT3 receptor antagonist that works by blocking the action of serotonin, a natural substance in the body that can trigger nausea and vomiting. Clinical trials have shown that ondansetron is effective in preventing chemotherapy-induced nausea and vomiting, making it a valuable option for cancer patients undergoing treatment.

Studies have demonstrated the efficacy of ondansetron in reducing the incidence and severity of nausea and vomiting associated with chemotherapy, improving the quality of life for patients and allowing them to complete their treatment regimens without interruptions due to these side effects.

Additional Information:

• Ondanset Solution for Injections is for intravenous or intramuscular use only.
• Store the vials at controlled room temperature between 20°C to 25°C (68°F to 77°F).
• Keep out of reach of children and away from light.